After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Voyager Therapeutics Inc is $204.13M. A total of 0.75 million shares were traded on the day, compared to an average of 726.96K shares.
In the most recent transaction, Ferguson Toby sold 19,000 shares of VYGR for 3.73 per share on Aug 18 ’25. After the transaction, the Chief Medical Officer now owns 138,914 company shares. In a previous transaction on Aug 18 ’25, Ferguson Toby bought 19,000 shares at 3.72 per share.
Among the insiders who sold shares, Ferguson Toby disposed of 10,086 shares on Apr 02 ’25 at a per-share price of $3.43. This resulted in the Chief Medical Officer holding 157,914 shares of VYGR after the transaction. In another insider transaction, Sandrock Alfred sold 10,885 shares at $3.43 per share on Apr 02 ’25. Company shares held by the President and CEO now total 430,931.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, VYGR has a high of $8.27 and a low of $2.64.
As of this writing, VYGR has an earnings estimate of -$0.52 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.6. The company reported an EPS of -$0.16 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VYGR’s latest balance sheet shows that the firm has $132.54M in Cash & Short Term Investments as of fiscal 2021. There were $44.18M in debt and $50.98M in liabilities at the time. Its Book Value Per Share was $4.40, while its Total Shareholder’s Equity was $95.06M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VYGR is Buy with a score of 4.83.
